GLMD

Galmed Pharmaceuticals Ltd.

0.68

USD

GLMD Earnings Reports

Positive Surprise Ratio

GLMD beat 23 of 36 last estimates.

64%

Next Report

Date of Next Report

Mar 31, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.52

Implied change from Q3 25 (Revenue/ EPS)

+57.58%

Implied change from Q4 24 (Revenue/ EPS)

Galmed Pharmaceuticals Ltd. earnings per share and revenue

On Nov 26, 2025, GLMD reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 40.09% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +12.40% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an increase of 57.58% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Galmed Pharmaceuticals Ltd.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Galmed Pharmaceuticals Ltd. reported EPS of -$0.33, beating estimates by 40.09%, and revenue of $0.00, -- -- expectations.

How did the market react to Galmed Pharmaceuticals Ltd.'s Q3 2025 earnings?

The stock price moved up 12.4%, changed from $0.82 before the earnings release to $0.92 the day after.

When is Galmed Pharmaceuticals Ltd. expected to report next?

The next earning report is scheduled for Mar 31, 2026.

What are the forecasts for Galmed Pharmaceuticals Ltd.'s next earnings report?

Based on 3 analysts, Galmed Pharmaceuticals Ltd. is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.